Skip to main content

Licensing & Technology Transactions

Solidly Structuring Our Clients’ Futures

All businesses can generate significant economic value with shrewd development, licensing, and commercialization. But structuring, negotiating, and documenting these intricate transactions wisely is critical. Mintz understands the nature and value of your intellectual property, down to the molecule, fiber optic or algorithm. And we appreciate how each transaction contributes to your overall strategy. That understanding informed our recent work on BeiGene, Ltd.'s strategic collaboration with Celgene Corporation — helping our client expand into new markets.

Sign up for insights

Share Awards
 

Our Experience

Case Study
Mintz represented BeiGene, Ltd. in its global strategic collaboration with Celgene Corporation to develop and commercialize BeiGene’s cell death protein 1 (PD-1) inhibitor tislelizumab (BGB-A317) for patients with solid tumor cancers. Mintz also assists BeiGene with licensing transactions.
Case Study
Mintz has represented oncology-focused biotherapeutic company Inhibrx LP since its inception. Mintz attorneys have advised Inhibrx on licensing deals and financing deals involving unusual corporate and tax structuring and international aspects.
Case Study
Mintz attorneys served as lead lawyers in the negotiation of a transaction for the procurement of a software as a service (SaaS) care management platform. The resulting arrangement greatly bolstered our client's bottom line.

Practice Areas

Our Approach

We leverage our significant industry experience, knowledge of technologies, and understanding of the marketplace to help clients craft strategies tailored to their strengths — and work with executive, scientific, and technology management to execute those business strategies through appropriately structured transactions.

Our Licensing & Technology Transactions client service teams include attorneys with experience in and knowledge of strategic alliances/collaboration structuring, technology development, finance, management and systems, clinical strategy, regulatory affairs, licensing, patents, mergers and acquisitions, tax (including multi-jurisdiction international taxation issues), manufacturing, distribution, accounting, product economics, and real estate.

We work with public and private companies, government entities, universities, and investors on transactions pertaining to everything from small but important day-to-day matters to multibillion-dollar international collaborations and global technology acquisitions and distribution arrangements.

Areas of Focus
  • Licensing and tech transfer
  • Collaborations, joint ventures, and strategic alliances
  • IP acquisitions and dispositions
  • Clinical trial arrangements
  • Royalty monetization
  • Advertising, marketing, and branding issues
IT Services
  • Procurement/sourcing of IT services and systems
  • Cloud services
  • Software development
  • Managed services
Product Pipeline Agreements
  • Manufacturing and supply arrangements
  • OEM arrangements
  • Reseller and distributor arrangements

Represent licensors, licensees, buyers, sellers, private equity and venture capital firms and their portfolio companies, boards of directors, financial advisors, management teams, and other participants.

What Our Clients Are Saying

Meet Mintz

Our experienced team leaders have handled everything from small but important day-to-day matters to multibillion-dollar international collaborations and global technology acquisitions.